Searched for
OXFORD ASTRAZENECA VACCINE
AstraZeneca jab uncertainty will hit Oxford BioMedica’s revenueIn a recent report, Oxford Biomedica warned that uncertainty surrounding AstraZeneca’s Covid-19 contract will bring reduction in earnings t...20 Apr, 2022, 10.05 PM IST- Oxford/AstraZeneca vaccine behind lower COVID deaths in UK, says expertDr Clive Dix, former chairman of the UK's Vaccine Task Force, told the 'Daily Telegraph' that the Oxford/AstraZeneca vaccine - manufactured...27 Dec, 2021, 04.18 PM IST
- EU regulator advices against second AstraZeneca shot in those with blood clotsThe advice for healthcare professionals was provided by the European Medicines Agency (EMA) as part of an ongoing review into rare, but sev...21 May, 2021, 06.59 PM IST
- Two AstraZeneca COVID shots could be 85-90% effective, UK real-world data suggestPHE said the preliminary findings were the first of its kind on the effectiveness of two doses of AstraZeneca in a real-world setting but c...20 May, 2021, 10.53 PM IST
- Two AstraZeneca Covid shots 85-90% effective: UK real-world analysisTwo doses of the Oxford/AstraZeneca Covid-19 vaccine are around 85% to 90% effective against symptomatic disease, Public Health England (PH...20 May, 2021, 09.15 PM IST
- UK scientists find higher risk of brain clots from COVID-19 compared with vaccinesA study of 500,000 COVID-19 patients found CVST had occurred at a rate of 39 people out of a million following infection, researchers said....15 Apr, 2021, 05.22 PM IST
- Sri Lanka temporarily suspends COVID-19 jabs due to delay in securing vaccines from SII: MinisterSri Lanka launched its inoculation programme in late January when India gifted 500,000 doses of Oxford-AstraZeneca. Till Thursday 913,219 p...02 Apr, 2021, 11.53 AM IST
- SII seeks Government's nod to give 50 lakh Covishield doses to UK, says won't affect India's vaccination driveIn a communique to Union Health Secretary Rajesh Bhushan on Tuesday, the Director of Government and Regulatory Affairs at the Pune-based Se...23 Mar, 2021, 08.32 PM IST
- Oxford study indicates AstraZeneca effective against Brazil variant, source saysThe data indicates that the vaccine will not need to be modified in order to protect against the variant, which is believed to have origina...05 Mar, 2021, 08.29 PM IST
- UK to receive 10 million AstraZeneca doses from Serum InstituteSII, the world’s largest vaccine manufacturer by volume, is mass producing the AstraZeneca vaccine, developed with Oxford University, for d...04 Mar, 2021, 12.18 AM IST
- AstraZeneca has sold its stake in Moderna for more than $1 billion: The TimesAstraZeneca is retaining partnership with Moderna on other disease treatments and could sell its AstraZeneca/Oxford University COVID-19 vac...01 Mar, 2021, 09.39 AM IST
- 2020's parting shot: India to roll out COVID-19 vaccine in January"India is a part of 'COVAX'. We will keep giving 50 per cent of everything we make to India and to COVAX at the same time. India has such a...29 Dec, 2020, 06.58 AM IST
- AstraZeneca's Covid-19 vaccine has a 'winning formula': Chief executive Pascal SoriotThe UK government announced on December 23 that the developers of the Oxford AstraZeneca vaccine had submitted their data to the Medicines ...28 Dec, 2020, 01.07 PM IST
- Oxford/AstraZeneca in ‘mix-match' COVID-19 vaccine trial with Russia's SputnikThe two sets of experts are to join forces to explore if a combination of the two jabs, both using a benign virus called adenovirus, could ...12 Dec, 2020, 06.04 PM IST
- Oxford, AstraZeneca COVID-19 vaccine trials resume days after pauseThe study had been previously stopped in July for several days after a participant who got the vaccine developed neurological symptoms; it ...12 Sep, 2020, 09.01 PM IST
- Serum Institute of India officially halts the trial of Astrazeneca-Oxford vaccine in India"We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We are following DCGI's instructions and wil...11 Sep, 2020, 06.54 AM IST
- India trials of COVID-19 vaccine is going on: Serum InstituteLast month, the Drug Controller General of India had granted permission to the Pune-based SII to conduct Phase-II and -III human clinical t...10 Sep, 2020, 12.08 PM IST
Load More
